Fine Mark National Bank & Trust Neogenomics Inc Transaction History

Fine Mark National Bank & Trust

$2.84 Billion
Q3 2024

A detailed history of Fine Mark National Bank & Trust transactions in Neogenomics Inc stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 29,908 shares of NEO stock, worth $441,741. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,908

Previous 29,908 -0.0%

Holding current value

$441,741

Previous $414,000 6.52%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$14.06 - $16.79 $1,532 - $1,830	-109 Reduced 0.36%	29,908 $470,000
Q4 2023 Feb 09, 2024	BUY	$11.67 - $20.73 $4,084 - $7,255	350 Added 1.18%	30,017 $485,000
Q1 2023 May 08, 2023	SELL	$9.09 - $19.45 $1,599 - $3,423	-176 Reduced 0.59%	29,667 $516,000
Q4 2022 Feb 09, 2023	BUY	$6.45 - $12.07 $1,838 - $3,439	285 Added 0.96%	29,843 $275,000
Q2 2022 Aug 09, 2022	SELL	$7.06 - $13.97 $1,765 - $3,492	-250 Reduced 0.84%	29,558 $241,000
Q4 2020 Feb 10, 2021	BUY	$36.08 - $56.47 $18,040 - $28,235	500 Added 1.71%	29,808 $1.61 Million
Q4 2019 Feb 07, 2020	BUY	$18.96 - $29.84 $8,532 - $13,428	450 Added 1.56%	29,308 $857,000
Q1 2019 May 07, 2019	BUY	$12.14 - $20.46 $3,642 - $6,138	300 Added 1.05%	28,858 $590,000
Q3 2018 Nov 02, 2018	SELL	$12.5 - $15.38 $4.38 Million - $5.38 Million	-350,000 Reduced 92.46%	28,558 $438,000
Q4 2017 Jan 30, 2018	SELL	$8.02 - $11.18 $200,500 - $279,500	-25,000 Reduced 6.19%	378,558 $3.35 Million
Q3 2017 Oct 30, 2017	BUY	$9.11 - $11.26 $3.68 Million - $4.54 Million	403,558	403,558 $4.49 Million

Others Institutions Holding NEO

# of Institutions

292

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.86B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Account

Fine Mark National Bank & Trust Neogenomics Inc Transaction History